 |
|
|
 |
| Profit & Loss |
|
|
2022/12 - Final
HKD($) | %Chg
(Final to Final) | 2021/12
HKD($) | 2020/12
HKD($) |
| Turnover | 0 | -- | 2,571,000 | 21,825,000 | | Cost of Sales | -- | -- | (1,585,000) | (21,649,000) | | Gross Profit | -- | -- | 986,000 | 176,000 | | Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | | Change in FV & Impairment on Others | -- | -- | -- | -- | | Profit / (Loss) on Disposal | (143,566,000) | 3604.929% | (3,875,000) | (949,000) | | Other Non-operating Items | -- | -- | -- | -- | | Share of Results of Asso. & JCEs | 0 | -- | (7,070,000) | (11,915,000) | | Profit / (Loss) before Taxation | (620,309,000) | 1022.670% | (55,253,000) | (100,791,000) | | Taxation | 0 | -- | 0 | 0 | | Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | | Non-controlling Interests | 61,000 | 335.714% | 14,000 | 27,887,000 | | Others | -- | -- | -- | -- | | Profit / (Loss) Attributable to Shareholders | (620,248,000) | 1022.844% | (55,239,000) | (72,904,000) | | Net Finance Costs / (Income) | 144,000 | -49.650% | 286,000 | 831,000 | | Depreciation & Amortisation | 485,000 | -88.063% | 4,063,000 | 12,239,000 | | Directors' Emoluments | -- | -- | 4,459,000 | 5,412,000 | | Auditor's Opinion Status | Disclaimer | -- | Disclaimer | Disclaimer | | | | Market Valuation Indicators | | EPS (cts) | -3.050 | -% | -0.270 | -0.360 | | DPS (cts) | 0.000 | -- | 0.000 | 0.000 | | Dividend Payout Ratio (%) | -- | -- | -- | -- | | Cash flow per share ($) | -- | -- | -0.001 | -0.005 | | NBV per share ($) | -0.009 | -% | 0.023 | 0.025 |
|
|
|
|
|
|
